logo
logo

Bio Fuse Medical Technologies Appoints Dr. David Battleman As President & Chief Executive Officer

Mar 26, 2024•over 1 year ago

Position

Chief Executive Officer

Company

BioFuse Medical Technologies

David Battleman
MelbourneMedical DeviceMedicalBiotechnologyHealth CareManufacturing

Description

Dr. David Battleman, MD, MBA, MSc, has been appointed as President & Chief Executive Officer of BioFuse Medical Technologies. His extensive experience in healthcare & life science technology development & commercialization makes him an ideal leader to guide BioFuse through its next phase of growth.

Company Information

Company

BioFuse Medical Technologies

Location

Melbourne, Florida, United States

About

BioFuse Medical Technologies, Inc. is a privately held medical device company headquartered in Melbourne, Florida. The company is dedicated to the development of the BioFuse Multi-Tissue Welder (MTW), an advanced electrosurgical platform designed to transform the current surgical landscape. The MTW technology is a breakthrough in multi-tissue welding, offering a proprietary high-frequency system that outperforms traditional sutures and staples, thereby enhancing patient outcomes and reducing healthcare costs. With a strong product pipeline, clear regulatory roadmap, and a market potential of $3 billion, BioFuse Medical Technologies is positioned to revolutionize and dominate the surgical suture, staple, and electrocautery vessel sealing markets in the United States and Europe.

Related People

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months